Nautilus Biotechnology, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.15M-0.12M-0.07M-0.08M
Gross Profit -0.15M-0.12M-0.07M-0.08M
Operating items
Research & Development 29.35M37.67M47.25M50.48M
Selling, General & Administrative 21.15M25.95M28.90M31.00M
Operating Expenses 50.50M63.62M76.15M81.48M
Non-operating items
Interest & Investment Income 0.33M5.82M12.55M10.78M
Non Operating Income 0.18M5.69M12.48M10.70M
Net income details
Profit After Tax -50.31M-57.92M-63.67M-70.78M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 19.19M124.17M124.72M124.95M125.56M